New COPD drug candidate EP395 put through interaction tests
NCT ID NCT06118684
First seen Apr 29, 2026 · Last updated May 23, 2026 · Updated 4 times
Summary
This study looked at how a new drug called EP395 interacts with other common medicines in 37 healthy adults. The goal was to check if EP395 changes how the body processes certain drugs, which is important for future use in people with COPD. Participants took EP395 along with other drugs to measure levels in the blood and track any side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COPD are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Clinical Trial Consultants AB
Uppsala, 75237, Sweden
Conditions
Explore the condition pages connected to this study.